Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome

Heart Rhythm. 2007 Apr;4(4):508-11. doi: 10.1016/j.hrthm.2006.12.031. Epub 2006 Dec 28.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Andersen Syndrome / complications
  • Andersen Syndrome / drug therapy*
  • Andersen Syndrome / genetics
  • Andersen Syndrome / therapy
  • Anti-Arrhythmia Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Defibrillators, Implantable
  • Female
  • Flecainide / therapeutic use*
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Mutation / genetics
  • Potassium Channels, Inwardly Rectifying / genetics
  • Recurrence
  • Siblings
  • Tachycardia, Ventricular / drug therapy*
  • Tachycardia, Ventricular / etiology
  • Tachycardia, Ventricular / therapy
  • Ventricular Premature Complexes / etiology
  • Ventricular Premature Complexes / therapy

Substances

  • Anti-Arrhythmia Agents
  • KCNJ2 protein, human
  • Potassium Channels, Inwardly Rectifying
  • Flecainide